Abstract
Analysis of pediatric deaths associated with pandemic A H1N1 influenza shows that fatal outcome is more likely in young children, under the age of 5. Neonates, because of the immaturity of their immune system, could represent a high-risk group for severe disease and fatal outcome. We present a group of five neonates with confirmed novel influenza A H1N1 infection. This report indicates that the full spectrum of influenza A H1N1 infection ranging from mild febrile illness with spontaneous recovery to severe disease with fatal outcome may be expected even in neonates.
MeSH terms
-
Antiviral Agents / administration & dosage
-
Diagnosis, Differential
-
Fatal Outcome
-
Female
-
Humans
-
Infant
-
Infant, Newborn
-
Infant, Premature, Diseases / diagnosis
-
Infant, Premature, Diseases / drug therapy
-
Infant, Premature, Diseases / mortality*
-
Influenza A Virus, H1N1 Subtype* / isolation & purification
-
Influenza, Human / diagnosis
-
Influenza, Human / drug therapy
-
Influenza, Human / mortality*
-
Male
-
Oseltamivir / administration & dosage
-
Pandemics*
-
Prognosis
-
Respiratory Insufficiency / diagnosis
-
Respiratory Insufficiency / drug therapy
-
Respiratory Insufficiency / mortality
-
Reverse Transcriptase Polymerase Chain Reaction
-
Risk Factors
Substances
-
Antiviral Agents
-
Oseltamivir